The global cannabis testing market size was valued at USD 1.28 billion in 2025 and is projected to grow from USD 1.45 billion in 2026 to USD 4.02 billion by 2034, registering a CAGR of 13.55% during the forecast period from 2026 to 2034. North America dominated the cannabis testing market with a market share of 46.5% in 2025.
Cannabis testing refers to the laboratory analysis of cannabis plants, extracts, and finished products to verify their quality, safety, and potency. It involves testing for cannabinoids, terpenes, pesticides, heavy metals, residual solvents, microbial contaminants, and moisture content. Cannabis testing helps producers meet regulatory standards, ensures product consistency, and provides consumers with safe, accurately labelled products for medical and recreational use.
Download a Free Sample To learn more about this report,
Expanded Pesticide Panels Are Increasing Cannabis Testing Complexity
The cannabis testing market trends show that expanding pesticide requirements are shifting laboratories toward broader contaminant screening and more specialized analytical methods. This transition is increasing testing complexity, with California’s 2026 pesticide requirements adding analytes and introducing revised action levels for cannabis products. The result is greater demand for validated laboratory methods capable of detecting a wider range of pesticide residues.
Edible Cannabis Is Driving Matrix-Specific Testing Methods
The growing variety of edible products is shifting laboratories toward testing methods designed for complex food-based matrices. This transition is increasing the need for specialized preparation and validation across products such as gummies and other cannabis-infused foods, with AOAC expanding proficiency-testing programs for cannabinoids, terpenes, pesticides, mycotoxins, heavy metals, and residual solvents in cannabis and hemp edibles. The result is broader laboratory capability for accurately testing diverse edible formulations.
Stricter Product Safety Standards and Cannabinoid Potency Verification Drive Market
Stricter product safety standards are creating recurring demand for laboratory testing before cannabis products reach consumers. California requires every batch to undergo testing for contaminants and accurate cannabinoid and terpene labeling, while laboratories must maintain ISO accreditation and validated procedures. These requirements create steady testing volumes for licensed laboratories across regulated cannabis supply chains.
Cannabinoid potency verification supports routine testing demand by requiring reliable measurement of THC, CBD, and other cannabinoids for product labeling and quality control. California requires a standardized HPLC method for regulatory cannabinoid testing of dried flower and non-infused pre-rolls, providing a real-world application of routine potency analysis. Accurate potency results help producers meet labeling requirements and maintain consistent products, supporting continued demand for analytical testing services.
High Testing Equipment Costs and Skilled Personnel Shortages Restrain Cannabis Testing Market Expansion
High costs for advanced analytical equipment increase the capital required to establish and maintain cannabis testing laboratories. These investment requirements can limit laboratory expansion and testing capacity, particularly for smaller testing facilities, slowing the availability of testing services.
Shortages of skilled analytical personnel limit the ability of testing laboratories to operate specialized instruments and maintain reliable testing workflows. Limited technical expertise can reduce laboratory throughput, increase training requirements, and delay the processing of cannabis samples, restricting market adoption.
Cannabis Water-Activity Testing and Terpene Profiling Services Create New Market Opportunities
Analytical laboratories, cannabis testing companies, and instrument manufacturers can benefit from water-activity testing for cannabis products, particularly dried flower and processed products. Companies such as METER Group can generate revenue through testing instruments, laboratory services, calibration, and related consumables while supporting cannabis testing market growth.
Testing laboratories, analytical service providers, and cannabis quality-assurance companies can expand into terpene profiling to assess aroma compounds and product characteristics. Companies such as SC Labs can generate revenue through specialized testing services, analytical equipment, and laboratory partnerships, creating additional commercial opportunities.
Inconsistent Testing Methodologies and Laboratory Quality-Control Gaps Hinder Cannabis Testing Market Growth
Inconsistent testing methodologies across laboratories can produce differences in cannabinoid and contaminant results for similar cannabis samples. Variations in sampling, preparation, analytical methods, and reporting make results harder to compare and can increase retesting and compliance requirements for cannabis producers. Thus, inconsistent testing methodologies become a major issue among key players.
Laboratory quality-control gaps can reduce confidence in the accuracy and reliability of cannabis test results, particularly when laboratories apply inconsistent quality-assurance procedures. In 2025, California regulators continued strengthening laboratory testing requirements to improve result reliability and address practices that could undermine testing integrity. Thus, laboratory quality-control gaps have become a major issue among key players.
The microbial analysis and potency testing segment accounted for a share of 61.3% in 2025 and is expected to grow at a CAGR of 12.8% during the forecast period 2026-2034, driven by its role in assessing microbial safety and cannabinoid concentration, supported by growing testing requirements for cannabis product quality and consistency.
The heavy metal testing segment focuses on detecting contaminants such as lead, mercury, and arsenic to support the safety and purity of cannabis products. It also helps laboratories verify compliance with regulatory limits and identify contamination risks arising from cultivation inputs, soil, water, or processing environments.
Request Customizationto receive a tailored report.
The cannabis cultivators segment accounted for a share of 57.4% in 2025, driven by the need for testing to assess cannabis quality and identify contaminants during cultivation. The segment supports quality monitoring across cultivation activities.
The cannabis drug manufacturers segment is expected to grow at a CAGR of 12.9% during the forecast period 2026-2034, driven by increasing demand for quality-controlled cannabis-based pharmaceutical products. The cannabis cultivators segment continues to require testing for cultivation-stage quality assessment.
Speak to an Analystto discuss market opportunities.
The North America cannabis testing market accounted for the largest regional share of 46.5% in 2025, driven by stringent regulatory testing requirements, increasing quality-control standards, and mandatory analytical testing for cannabinoid content, contaminants, pesticides, and other safety parameters across regulated cannabis markets. The U.S. cannabis testing market is supported by the USDA’s extension of mandatory DEA-registered laboratory testing for hemp through December 31, 2026, with full enforcement expected thereafter, increasing the need for compliant laboratories and standardized THC testing services.
The Canada cannabis testing market is fuelled by Health Canada’s 2026–2028 regulatory plan, which includes updated cannabis testing and reporting requirements, while mandatory pesticide testing requirements were updated in 2026 and continue to require laboratories to meet specified analytical detection limits, strengthening future demand for compliant cannabis testing services.
Unlock Regional Insightsto access country-level data, & regional trends.
The Europe cannabis testing market is expected to grow at a CAGR of 14.6% during the forecast period 2026-2034, showcasing the fastest-growing regional market, propelled by evolving cannabis regulations, stricter THC and contaminant testing requirements, and increasing demand for standardized analytical testing across European markets. The U.K. cannabis testing market is supported by the FSA’s ongoing assessment of hundreds of CBD product applications for novel-food authorization, while UK Government guidance requires CBD products to demonstrate controlled-cannabinoid levels through appropriately sensitive testing by ISO/IEC 17025-accredited laboratories, strengthening future demand for compliant cannabis testing services.
The Germany cannabis testing market is driven by Germany’s projected comprehensive evaluation of the Cannabis Act, which is scheduled for completion by April 2028, while cannabis consumption in 2024 was estimated at 670–823 tonnes, increasing the need for quality, potency, and contaminant testing as the regulated market develops.
The Asia-Pacific cannabis testing market accounted for a 16.2% share and is expected to grow at a CAGR of 12.9% during the forecast period 2026-2034, supported by evolving cannabis regulations, increasing emphasis on product safety and quality, expanding medicinal cannabis applications, stricter requirements for cannabinoid and contaminant analysis, and growing adoption of standardized laboratory testing across the region. The Japan cannabis testing market is fuelled by Japan’s strict Δ9-THC residual limits of 10 ppm for oils and powders, 0.10 ppm for aqueous solutions, and 1 ppm for other products, while the Ministry of Health, Labour and Welfare listed laboratories capable of measuring Δ9-THC concentrations in products as of August 2026, strengthening demand for compliant analytical testing services.
The China cannabis testing market is propelled by China’s continued expansion of regulated analytical capabilities, including a national inspection framework that in 2026 covers 120 testing institutions across key sectors, while a customs testing standard for detecting THC, CBD, and CBN in cosmetics came into effect in July 2026, creating additional requirements for specialized cannabinoid identification and quantification testing.
The cannabis testing market competitive landscape is moderately fragmented, with competition comprising analytical instrument manufacturers, laboratory technology providers, specialized cannabis testing laboratories, and analytical testing solution companies. Key players such as Agilent Technologies Inc., Danaher Corporation, Merck KGaA, PerkinElmer, and SC Laboratories collectively are estimated to account for approximately 25–30% of the global cannabis testing market share.
Established players compete primarily on analytical accuracy, testing capabilities, regulatory compliance, and laboratory technology. Emerging and regional players in the cannabis testing market ecosystem compete through specialized testing panels, faster turnaround times, cannabis-specific analytical methods, and integrated data-management services.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Antibody Purification Service Market Size, Forecast, Demand, Opportunities, 2034
Red Biotechnology Market Size, Share, Growth, Forecast, 2034
Cell Culture Market Size, Share, Growth, Analysis, Report, 2034
Cell Line Development Services Market Size, Share, 2034
Base Editing Market Size, Share, Growth, Analysis, Report, 2034
Metagenomic Sequencing Market Size, Share, Growth, Analysis, 2034
We are featured on:
sales@straitsresearch.com